Moderna said the pivotal last-stage study of its experimental coronavirus vaccine began Monday, with the first subjects receiving doses
Two of the most advanced experimental coronavirus vaccines entered the pivotal phase of their studies on Monday, with the first subjects receiving doses of Moderna Inc.’s vaccine and Pfizer Inc. readying to inject participants in its trial.
Researchers evaluating the vaccines plan to enroll 30,000 people in separate last-stage, or phase 3 trials, results of which will determine whether the vaccines protect against symptomatic Covid-19, and whether they should be cleared for widespread use.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Pfizer and BioNTech began late-stage human trial for coronavirus vaccine Monday
続きを読む »
Stocks making the biggest moves after hours: Pfizer, F5 Networks, Virgin Galactic and moreSee which stocks are posting big moves after the bell.
続きを読む »
Moderna’s Coronavirus Vaccine Begins Final-Stage TestingModerna’s pivotal vaccine trial will evaluate, in 30,000 subjects across the U.S., whether two doses protects against symptomatic Covid-19
続きを読む »
Pfizer and BioNTech began late-stage human trial for coronavirus vaccine Monday
続きを読む »
Final test of Moderna's coronavirus vaccine — in 30,000 volunteers — gets underwayThe world's biggest COVID-19 vaccine test got underway Monday with the first of 30,000 planned volunteers.
続きを読む »
COVID Vaccine Candidate Now in Final Phase TestingThis is only one of the many vaccines under development worldwide. Other trials are underway in China and Britain, and final tests have started in Brazil and other countries.
続きを読む »